Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-03-17
1995-08-08
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514815, A61K 3116
Patent
active
054399394
ABSTRACT:
This invention relates to treatment of betaglobin disorders, such as sickle-cell anemia and beta-thalassemia, by administering compositions of isobutyramide.
REFERENCES:
patent: 4482571 (1984-11-01), Abraham
patent: 4822821 (1989-04-01), Perrine
patent: 5025029 (1991-06-01), Perrine
Chemical Abstracts 111(13): 110867f, 1989, Lundquist et al.
Aldrich Handbook of Organic Chemicals, Aldrich Chemical Co., Inc., 1972, U.S.A., p. 385.
Goodman Gilman et al. (Editors), The Pharmacological Basis of Therapeutics (6th Ed.), New York, MacMillan, 1980, p. 15.
Perrine, S., et al., "Butyric Acid Analogues Augment .gamma. Globin Gene Expression in Neonatal Erythroid Progenitors," Biochem. Biophys. Res. Commun. 148(2):694-698 (1987).
Perrine, S., et al., "Inhibition of fetal globin gene switching in vivo in human and ovine fetuses," Alan R. Liss, Inc.: Developmental Control of Globin Gene Expression 545-554 (1987).
Perrine, S., et al., "Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching," Proc. Natl. Acad. Sci. USA 85:8540-8542 (Nov. 1988).
Perrine, S., et al., "Sodium Butyrate Enhances Fetal Globin Gene Expression in Erythroid Progenitors of Patients With Hb SS and .beta. Thalassemia," Blood 74(1):454-459 (Jul. 1989).
Perrine, S., et al., "Butyrate analogues modulate globin gene expression in human and ovine ertyhroid cells," Alan R. Liss, Inc.: Hemoglobin Switching, Part B: Cellular and Molecular Mechanisms 341-350, (1989).
Perrine, S., et al., "Stopping the Biologic Clock for Globin Gene Switching," Sixth Cooley's Anemia Symposium: Annals of the New York Academy of Sciences, 612:134-140 (1990).
Perrine, S., et al., "Pharmacologic prevention and Reversal of Globin Gene Switching," The Johns Hopkins University Press: The Regulation of Hemoglobin Switching 425:436 (1991).
Constantoulakis, P. et al., Trans. Assoc. Am. Physicians 103: 80-89 (1990).
Constantoulakis, P. et al., "Alpha-amino-n-butyric Acid Stimulates Fetal Hemoglobin in the Adult", Blood 72: 1961-1967 (1988).
Daniel, P. et al., "Pharmacokinetic Study of Butyric Acid In Vivo as Sodium and Arginine Butyrate Salts", Clin. Chem. Acta 181: 255-263 (1989).
Karlsson, S. and Nienhuis, A. W., "Developmental Regulation of Human Globin Genes", Annu. Rev. Biochem. 54: 1071-1108 (1985).
Miller, A. A. et al., Eur. J. Cancer Clin. Oncol. 23: 1283-1287 (1987).
Murata et al., J. Ferment. Technol. 66(5): 501-507 (1988).
Noguchi et al., "Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease", N. Eng. J. Med. 318: 96-99 (1988).
Olivieri, N. F. et al., "Butyrate Stimulates Gamma-Globin Synthesis in Patients with Beta-globin Gene Disorders", Blood 78: 368a (1991).
S. P. Perrine, et al., "An Orally Bioavailable Butyrate Analog Stimulates Fetal Globin Gene Expression In Vivo", Abstract in the 17th Annual Sickle Cell Disease Conference Meharry Medical College, p. 140a (Mar. 14, 1992).
S. P. Perrine, "Pharmacological Modulation of Fetal Globin Gene Expression in the Perinatal Period", Semin. Perinatol., 14(5): 346-350 (1990).
S. P. Perrine et al., "Butyric Acid Modulates Developmental Globin Gene Switching in Man and Sheep", Adv. Exp. Med. Biol., 271: 177-183 (1989).
Perrine, S. P. et al., "Sodium Butyrate Enhances Fetal Globin Gene Expression in Erythroid Progenitors of Patients with Hb SS and Beta-Thalassemia," Blood 74(1): 454-459 (Jul. 1989).
Perrine, S. P. et al., "Delay in the Fetal Globin Switch in Infants of Diabetic Mothers", N. Engl. J. Med. 312: 334-338 (1985).
Schechter, A. N. and Noguchi, C. T., "Inhibition of Sickle Hemoglobin Gelation by Peptides", In: Development of Therapeutic Agents for Sickle Cell Disease, eds. J. Rosa, Y. Beuzard and J. Hercules, North-Holland Publishing Company, Amsterdam-New York-Oxford (1979).
Tsuji et al., "Structural and Biological Identity of Recombinant EDF (Erythroid Differentiation Factor) with Natural EDF", Agric. Biol. Chem. 52(9): 2143-2148 (1988).
Wood, W. G., et al., "HbF Synthesis in Sickle Cell Anemia: a Comparison of Saudi Arab Cases with Those of African Origin", Br. J. Haematol. 45: 431-445 (1980).
Children's Hospital Medical Center of Northern California
Cintins Marianne M.
Haley, Jr. James F.
Moezie M.
Pierri Margaret A.
LandOfFree
Pharmaceutical compositions and methods using isobutyramide for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods using isobutyramide for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods using isobutyramide for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971617